Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating activated white blood cells with autologous stem cell transplant for newly diagnosed multiple myeloma co…
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma [Phase 3]
A Phase 3 trial comparing daratumumab plus Velcade, melphalan, and prednisone (DVMP) with Velcade-melphalan-prednisone (VMP) in previously u…
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma [Phase 3]
Phase 3 trial comparing once-weekly versus twice-weekly carfilzomib plus dexamethasone in adults with relapsed/refractory multiple myeloma c…
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating tadalafil with lenalidomide and dexamethasone in multiple myeloma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Feasibility and safety study of a dual specificity CD38 and BCMA CAR-T cell therapy for relapsed or refractory multiple myeloma is being in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM) [Phase 1, Phase 2]
Phase 1/2 trial evaluating allo stem cell transplant followed by lenalidomide and sirolimus maintenance in high-risk multiple myeloma; study…
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial update evaluating daratumumab with ixazomib and dexamethasone in relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Reduced Intensity Double Umbilical Cord Blood Transplantation [Phase 2]
Phase 2 results for reduced-intensity double umbilical cord blood transplantation were completed and results posted in 2018. The study evalu…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma [EARLY_Phase 1]
Early-phase clinical trial evaluating interferon alfa and interleukin-6 in patients with recurrent multiple myeloma; study terminated with r…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans [Phase 2]
Phase 2 clinical trial evaluating pomalidomide with cyclophosphamide and dexamethasone for relapse/refractory multiple myeloma; safety profi…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain [NA]
A completed clinical trial evaluating ExAblate MR-guided focused ultrasound for palliation of pain in bone metastases and multiple myeloma; …
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 1]
Phase 1 pharmacokinetic study of oral ixazomib with lenalidomide and dexamethasone in adult Asian patients with relapsed/refractory multiple…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement [Phase 3]
Phase 3 trial evaluating zoledronic acid for bone involvement in metastatic breast cancer, metastatic prostate cancer, or multiple myeloma; …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma [Phase 2]
Phase 2 trial evaluating TMC (topotecan, cyclophosphamide, and melphalan) for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer [NA]
Clinical trial update on vertebral augmentation and radiotherapy for collapse spinal metastatic cancer has been terminated with results post…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Thalidomide for Multiple Myeloma [Phase 3]
Phase 3 clinical trial update for thalidomide in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Thalidomide-Dexamethasone for Multiple Myeloma [Phase 2, Phase 3]
Phase 2/3 trial update of thalidomide-dexamethasone for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction [Phase 1, Phase 2]
Phase 1/2 trial evaluating lenalidomide with low-dose dexamethasone in previously treated multiple myeloma patients with kidney dysfunction;…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) [Phase 2]
Phase 2 trial evaluating the combo of Daratumumab plus Durvalumab in relapsed and refractory multiple myeloma has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating Th1/Tc1 immunotherapy after stem cell transplantation in multiple myeloma; the study status is terminated with re…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma [Phase 2]
Phase 2 trial evaluating melphalan plus bortezomib as conditioning before autologous and allogeneic stem cell transplants in multiple myelom…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation [Phase 2]
Phase 2 pharmacokinetic study of propylene glycol-free melphalan HCl for myeloablative conditioning in autologous stem cell transplant for m…
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001) [Phase 1]
Phase 1 dose-finding study of the bromodomain inhibitor birabresib (OTX015/MK-8628) in hematologic malignancies has completed with results p…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [Phase 2]
Phase 2 trial evaluating cyclosporine with T-cell add-back in blood cell transplant settings for hematologic cancers, including chronic lymp…
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
Clinical trial update combining chemotherapy, vaccine therapy, and stem cell transplantation in newly diagnosed multiple myeloma; phases 1 a…